Ignite Creation Date:
2024-06-16 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06427226
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-23
First Post:
2024-05-18
Brief Title:
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity
Sponsor:
Tanta University
Organization:
Tanta University
Organization Data
Organization:
Tanta University
Class:
OTHER
Study ID:
Dapagliflozin in breast cancer
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tanta University
Lead Sponsor Class:
OTHER
Responsible Party:
Sandy Ehab Nabil Rezkallah
Responsible Party Title:
Clinical Pharmacist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tanta University
Old Name:
None
Old Organization:
None